105496-4
A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
Active
Fully-Specified Name
- Component
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
- Property
- Find
- Time
- Pt
- System
- ^Patient
- Scale
- Ord
- Method
Additional Names
- Short Name
- Not in the expected range of benefit
Survey Question
- Text
- A study found that chemotherapy decreased the risk of dying from colon cancer by about 30%. The study was 95% sure that the real benefit was between 10% and 50%. Which of the following is not in the expected range of benefit?
- Source
- PX280201110000
Example Answer List: LL6653-1
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| 11% decrease in risk | LA34245-3 | ||
| 30% decrease in risk | LA34246-1 | ||
| 45% decrease in risk | LA34247-9 | ||
| 95% decrease in risk | LA34248-7 |
Basic Attributes
- Class
- PHENX
- Type
- Clinical
- First Released
- Version 2.78
- Last Updated
- Version 2.78
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 105506-0 | PhenX - health numeracy protocol 280201 |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=105496-4
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright